PAMELA ARGEREOW: Open Payments
NPI 1013087758 · SOUTH PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 17 payments from 10 companies in 2025. Trend: 2023 $81 · 2024 $1,822 · 2025 $572
Food & beverage: $504Education: $68
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $166 |
| Janssen Biotech, Inc. | 2 | $101 |
| Olympus America Inc. | 3 | $70 |
| 180 Medical, Inc. | 2 | $58 |
| TOLMAR, INC. | 2 | $51 |
| UROGEN PHARMA, INC. | 1 | $44 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: GEMTESA, ERLEADA, iTIND System, JATENZO, ZUSDURI, GENTLECATH, CURE CATHETER, MYRISK.
Industry payments across ME — which companies pay providers there.
